Moreover, we demonstrated that HCC-SR cells can be sensitized to sorafenib-induced ferroptosis both in vivo and in vitro via the FASN/HIF1α/SLC7A11 pathway. The gene discussed is FASN; the disease is hepatocellular carcinoma.